ML281 CAS:1404437-62-2
ML281
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1502 | 100mg | 425.00 | + Add to cart |
|
| R-C-1502 | 200mg | 705.00 | + Add to cart |
|
| R-C-1502 | 500mg | 1280.00 | + Add to cart |
|
|
|
||||
Product description
ML-281 is a potent ans selective STK33 inhibitor(IC50=14 nM).ML281 showed low nanomolar inhibition of purified recombinant STK33 and a distinct selectivity profile as compared to other STK33 inhibitors.ML281 is a valuable addition to small-molecule probes of STK33.v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog(KRAS)is the most mutated oncogene, and KRAS mutations have been found in up to 20% of all human tumors.STK33 was selectively toxic to KRAS-dependent cancer cell lines,suggesting that small-molecule inhibitors of STK33 might selectively target KRAS-dependent cancers.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---ML281
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


